Cargando…

Therapeutic potential of long-acting opioids and opioid antagonists for SARS-CoV-2 infection

Detalles Bibliográficos
Autores principales:	Eagleton, Marie, Stokes, Siobhan, Fenton, Fiona, Keenan, Eamon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	British Journal of Anaesthesia. Published by Elsevier Ltd. 2021
Materias:	COVID-19 Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418909/ https://www.ncbi.nlm.nih.gov/pubmed/34556330 http://dx.doi.org/10.1016/j.bja.2021.08.022

Ejemplares similares

Does opioid substitution treatment have a protective effect on the clinical manifestations of COVID-19? Comment on Br J Anaesth 2020; 125: e382–3
por: Eagleton, Marie, et al.
Publicado: (2021)

Propofol and SARS-CoV-2 infection
por: Hirota, Kazuyoshi, et al.
Publicado: (2020)

“A Lot of Things Stopped with COVID”: Screening Pregnant Patients for Opioid Use and Related Conditions During the COVID-19 Pandemic
por: Foti, Tara R., et al.
Publicado: (2023)

Retracted papers on SARS-CoV-2 and COVID-19
por: Cortegiani, Andrea, et al.
Publicado: (2021)

Anaesthesia-related drugs and SARS-CoV-2 infection
por: Hirota, Kazuyoshi, et al.
Publicado: (2021)

Episodic long-term memory in post-infectious SARS-CoV-2 patients
por: Aiello, Edoardo Nicolò, et al.
Publicado: (2021)

Mental Health Impact of SARS-COV-2 Pandemic on Long-Term Care Facility Personnel in Poland
por: Senczyszyn, Adrianna, et al.
Publicado: (2020)

Mandatory preoperative SARS-CoV-2 infection screening policies for paediatric surgery
por: Colas, Anne-Emmanuelle, et al.
Publicado: (2021)

Ozone (O3) and SARS-CoV-2: Physiological Bases and Their Therapeutic Possibilities According to COVID-19 Evolutionary Stage
por: Fernández-Cuadros, Marcos Edgar, et al.
Publicado: (2020)

Air filtration and SARS-CoV-2
por: Nazarenko, Yevgen
Publicado: (2020)

Neurological Complications of SARS-CoV, MERS-CoV, and COVID-19
por: Alshebri, Munirah Saad, et al.
Publicado: (2020)

Correction to: A cross‑section observational study on the seroprevalence of antibodies to COVID‑19 in patients receiving opiate agonist treatment
por: Fenton, Fiona, et al.
Publicado: (2021)

A cross-section observational study on the seroprevalence of antibodies to COVID-19 in patients receiving opiate agonist treatment
por: Fenton, Fiona, et al.
Publicado: (2021)

Antidiabetes Agents against Sars-Cov-2 Infection
por: Vitiello, Antonio, et al.
Publicado: (2020)

Re-reading the SARS-COV-2 Epidemic in Bergamo
por: Schena, Daniele, et al.
Publicado: (2020)

Infections sévères à SARS-CoV-2
por: Taghboulit, N., et al.
Publicado: (2021)

Association between stopping universal SARS-CoV-2 admission testing and hospital-onset SARS-CoV-2 in England and Scotland
por: Pak, Theodore, et al.
Publicado: (2023)

Labile PT-INR in a Covid-19 Patient Under Long-term Vitamin K Antagonist Therapy: a Case Report
por: Trevisan, Caterina, et al.
Publicado: (2020)

The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression
por: Pivniouk, Vadim, et al.
Publicado: (2022)

Estimating the asymptomatic proportion of SARS-CoV-2 infection in the general population: Analysis of nationwide serosurvey data in the Netherlands
por: McDonald, Scott A., et al.
Publicado: (2021)

Haemodynamic impact of positive end-expiratory pressure in SARS-CoV-2 acute respiratory distress syndrome: oxygenation versus oxygen delivery
por: Barthélémy, Romain, et al.
Publicado: (2021)

The SARS-CoV-2 Outbreak: an Epidemiological and Clinical Perspective
por: Wong, Rebecca S. Y.
Publicado: (2020)

Diaphragmatic myoclonus due to SARS-CoV-2 infection
por: Borroni, Barbara, et al.
Publicado: (2020)

SARS-CoV-2, an Underestimated Pathogen of the Nervous System
por: Jakhmola, Shweta, et al.
Publicado: (2020)

Nutritional status in post SARS-Cov2 rehabilitation patients
por: Gobbi, M., et al.
Publicado: (2022)

Dysphagia and mechanical ventilation in SARS-COV-2 pneumonia: It's real
por: Bordejé Laguna, Luisa, et al.
Publicado: (2022)

SARS-CoV-2 vaccine-related neurological complications
por: Oonk, Nicol G. M., et al.
Publicado: (2022)

A Cluster of Aspergillosis Associated with SARS-CoV-2
por: VerLee, Kerrie, et al.
Publicado: (2021)

Mitigation Strategies to Reduce Aerosolization of SARS-CoV-2
Publicado: (2022)

Postacute sequelae of SARS-CoV-2 (PASC) in nursing home residents: A case–control study
por: Clark, Sophie, et al.
Publicado: (2022)

The Evidence for High-Titer Convalescent Plasma in SARS-CoV-2
por: Fisher, David L., et al.
Publicado: (2021)

Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel
por: Reicher, Shay, et al.
Publicado: (2021)

Broken Heart (Takotsubo) Syndrome Triggered by SARS-CoV-2
por: Finsterer, Josef
Publicado: (2021)

Asthma and viruses: A focus on rhinoviruses and SARS-CoV-2
por: Padayachee, Yorissa, et al.
Publicado: (2021)

Thoracic sarcopenia as a predictive factor of SARS-COV2 evolution
por: Koehler, J., et al.
Publicado: (2022)

Seroepidemiology of SARS-CoV-2, Yamagata, Japan, June 2020
por: Morikane, Keita, et al.
Publicado: (2021)

Cognitive phenotyping of post-infectious SARS-CoV-2 patients
por: Aiello, Edoardo Nicolò, et al.
Publicado: (2022)

Animal Models to Study Emerging Technologies Against SARS-CoV-2
por: Mullick, Jhinuk Basu, et al.
Publicado: (2020)

Protective Effects of CVD and DM Medications in SARS-CoV-2 Infection
por: Bangi, Shifa, et al.
Publicado: (2020)

SARS-CoV-2-Related Kidney Injury: Current Concern and Challenges
por: Cheng, Yongqian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_022f6fiav1mjtgq0ih4dkleac5